Nearly 20% of drugs sold in India fake

May 15th, 2008|

ASSOCHAM estimates that the spurious drug market is growing at 25% annually. In fact, the Organization for Economic Cooperation and Development's latest figures say 75% of fake drugs supplied the world over have their origins in India.

Kinship launches new product for drug discovery

May 14th, 2008|

The Chennai based Kinship Technologies Private Ltd has launched a new product called iDERT (Integrated Data Extraction and Reporting Tool) which will enable Pharmaceutical and Biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products.

USFDA nod for dental agent of Novalar gets

May 14th, 2008|

Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company has received  approval from  United States Food and Drug Administration (USFDA) for  marketing approval for OraVerse (phentolamine mesylate).

USFDA approves Strattera for ADHD

May 14th, 2008|

United States Food and Drug Administration (FDA) has approved Eli Lilly Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.

Dr BR Jagashetty is new Drugs Controller of Karnataka

May 14th, 2008|

Karnataka government has appointed Dr Bharatesh R Jagashetty, as the Drugs Controller for Government of Karnataka with effect from May 1, 2008.

BioSyent Pharma sets up Secures First Supply Contract and Orders for New Product

May 14th, 2008|

BioSyent Inc. has established a new Hospital Products Division focused on licensing or acquiring pharmaceutical products used primarily in a hospital setting, and marketing those products across Canada.

Investment & Growth Opportunities in Tamil Nadu

May 13th, 2008|

U.S.-India Business Council and Caterpillar, Inc. is organizing a roundtable briefing on 'Investment & Growth Opportunities in Tamil Nadu' with Mr. L.K. Tripathy Chief Secretary Government of Tamil Nadu on  May 19th  2008 at 8:30 am – 10:30 am at the St. Regis San Francisco, 125 Third Street , San Francisco, CA  94103

CRAMS Hold Huge Prospects for Indian Pharma Units

May 13th, 2008|

CRAMS Hold Huge Prospects for Indian Pharma Units Contract Research and Manufacturing Services utilising excess manufacturing capacities.They have (CRAMS), is becoming one of the most promising moved into providing drug discovery, custom chemical opportunities for the Indian pharmaceutical industry…[English]-[French]-[Spanish]

Ranbaxy signs drug research pact Merck

May 13th, 2008|

Ranbaxy Laboratories Ltd. has tie-up with global pharma major Merck & Co. to drug discovery and development. The strategic product development agreement calls for joint research to develop clinically validated anti-bacterial and anti-fungal drug candidates.

Merck gets two patents for drugs for dyslipidemia and obesity in India

May 13th, 2008|

US-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity. The two new patented drugs are in final stages of trial and are yet to receive the Drug Controller General of India’s (DCGI) approval.

USFDA approves NovoSeven RT a new formulation of coagulation therapy

May 13th, 2008|

The US Food and Drug Administration has approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood.

MCC approves nine products of Aurobindo

May 13th, 2008|

Aurobindo receives approval from Medicines Control Council (MCC) to market nine  products in South Africa. The products are said to have a generic market size of 165 million South African brands in the local market

Quintiles to acquire consulting firm

May 12th, 2008|

Quintiles Transnational Corp. has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.

Institute for OneWorld Health sets up Strategic Advisory Board for diarrhoeal disease programme

May 12th, 2008|

The Institute for OneWorld Health, a US-based non-profit pharmaceutical company which develops drugs for infectious diseases in the developing world has formed a Strategic Advisory Board to support the iOWH Diarrhoeal Disease Program (DDP).

USFDA approves new labeling for Abilify

May 12th, 2008|

US Food and Drug Administration has approved updated labeling for Abilify, a drug made jointly by Bristol-Myers Squibb and Japan’s Otsuka Pharmaceuticals.

Ayurveda cluster planned to be set up in Maharashtra

May 12th, 2008|

The Ayurveda drug industry is growing at an estimated 15% in India and Maharashtra state Rs 16-crore Ayurved Cluster in Maharashtra by the Central Government.

Antibiotics lead Pharma Retail Market

May 12th, 2008|

Antibiotics and anti-bacterial drugs dominated domestic pharma retail market in the  first quarter (January-March) of the financial year. These include Augmentin (manufactured by GlaxoSmithKline), Mox (Ranbaxy), Zifi (FDC Ltd) and Taxim (Alkem).

Jubilant buys Speciality Molecules to strengthen Pyridine portfolio

May 9th, 2008|

Jubilant Organosys has acquired 100 per cent stake  in Speciality Molecules Pvt. Ltd for Rs 199.5 million on a debt free, cash free basis.

Delay in finalization of New Pharmaceutical Policy

May 8th, 2008|

Parliamentary Consultative Committee of Chemicals and Fertilizers Ministry expresses concern over the delay in finalization of New Pharmaceutical Policy

Roxane Lab launches Acarbose Tablets

May 8th, 2008|

Roxane Laboratories, Inc. has received the approval of their Abbreviated New Drug Application for Acarbose Tablets, 25mg, 50mg, and 100mg.